Cingulate (CING) EPS (Diluted) (2022 - 2026)
Cingulate (CING) EPS (Diluted) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 0.15 |
| 10 | Cingulate | 72.26 Mn | 72.26 Mn | - | -0.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.16 |
| Dec 31, 2025 | -1.19 |
| Sep 30, 2025 | -1.38 |
| Mar 31, 2025 | -0.99 |
| Dec 31, 2024 | -4.11 |
| Sep 30, 2024 | -2.20 |
| Jun 30, 2024 | -5.15 |
| Mar 31, 2024 | -5.79 |
| Dec 31, 2023 | -86.87 |
| Sep 30, 2023 | -68.58 |
| Jun 30, 2023 | -107.27 |
| Mar 31, 2023 | -80.29 |
| Dec 31, 2022 | -86.61 |
| Sep 30, 2022 | -67.52 |
| Jun 30, 2022 | -67.74 |